BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33625349)

  • 21. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of
    Meredith G; Wong D; Yaxley J; Coughlin G; Thompson L; Kua B; Gianduzzo T
    BJU Int; 2016 Oct; 118 Suppl 3():49-55. PubMed ID: 27659411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
    Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
    Zagars GK
    J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
    Zagars GK; von Eschenbach AC; Ayala AG
    Cancer; 1993 Sep; 72(5):1709-25. PubMed ID: 7688659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic prostate metastases to the brain parenchyma: report of two cases and review of the literature.
    Tsai V; Kim S; Clatterbuck RE; Ewend MG; Olivi A
    J Neurooncol; 2001 Jan; 51(2):167-73. PubMed ID: 11386414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain stem metastasis as the only site of spread in prostate carcinoma. A case report.
    Gupta A; Baidas S; Cumberlin RK
    Cancer; 1994 Nov; 74(9):2516-9. PubMed ID: 7923009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volume of Gleason pattern 4 stratifies risk of metastasis and death in patients with Gleason score 3+5=8/5+3=8 positive prostate core biopsies.
    Acosta AM; Taplin ME; Mata DA; D'Amico AV; Hirsch MS
    Hum Pathol; 2020 May; 99():62-74. PubMed ID: 32171650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic brain tumor from the prostate: two unusual cases.
    Smith VC; Kasdon DL; Hardy RC
    Surg Neurol; 1980 Sep; 14(3):189-91. PubMed ID: 7434183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
    Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
    Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of brain metastasis associated with prostate cancer].
    Soga N; Sugimura Y
    Hinyokika Kiyo; 2004 Jan; 50(1):37-40. PubMed ID: 15032014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple fossa metastasis of prostate cancer.
    Kwee IL; Nakada T; St John JN
    Neurosurgery; 1983 Nov; 13(5):584-6. PubMed ID: 6646385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late recurrence of a prostatic adenocarcinoma as a solitary splenic metastasis.
    Compérat E; Azzouzi AR; Chartier-Kastler E; Ménégaux F; Capron F; Richard F; Charlotte F
    Urol Int; 2007; 78(1):86-8. PubMed ID: 17192740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracranial metastatic adenocarcinoma of the prostate presenting as visual disturbance.
    Preston DM; Zeidman SM; Spevak M; Moul JW; Costabile RA
    Tech Urol; 1997; 3(1):51-3. PubMed ID: 9170227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
    Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
    Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solitary testicular metastasis from prostate cancer: a rare case of isolated recurrence after radical prostatectomy.
    Janssen S; Bernhards J; Anastasiadis AG; Bruns F
    Anticancer Res; 2010 May; 30(5):1747-9. PubMed ID: 20592373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Rare Presentation of Low-Grade Prostate Adenocarcinoma as Delayed Pineal Region Metastasis: A Case Report and Review of Multicenter Clinical Experience in Prostate Carcinoma Brain Metastases.
    Movahed-Ezazi M; Skalina KA; Parashar K; Manjila S; Vdovenko A; Iannuzzi C; Cartun RW
    J Neuropathol Exp Neurol; 2021 Dec; 80(12):1128-1133. PubMed ID: 34388234
    [No Abstract]   [Full Text] [Related]  

  • 38. Carcinoma of the prostate: brain stem metastasis as the only site of spread.
    Salvati M; Cervoni L
    Tumori; 1997; 83(4):776-8. PubMed ID: 9349321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous metastasis of prostatic adenocarcinoma: a cautionary tale.
    Rattanasirivilai A; Kurban A; Lenzy YM; Yaar R
    J Cutan Pathol; 2011 Jun; 38(6):521-4. PubMed ID: 21306410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracranial metastasis from prostatic adenocarcinoma simulating a meningioma.
    Lath CO; Khanna PC; Gadewar S; Patkar DP
    Australas Radiol; 2005 Dec; 49(6):497-500. PubMed ID: 16351616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.